Is this you? Create Your Porfile
Avatar

Pandey Anjali

Kyowa Hakko Kirin Co., Ltd.

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Pandey Anjali is active.

Explore More

Publication

Featured researches published by Pandey Anjali.

Archive | 2008

Compositions and method for inhibiting TGF-beta

Scarborough Robert M; Pandey Anjali; Mehrotra Mukund

Archive | 2017

2,6-ΔΙΑΜΙΝΟ-ΠΥΡΙΜΙΔΙΝ-5-ΥΛΟ-ΚΑΡΒΟΞΑΜΙΔΙΑ ΩΣ ΑΝΑΣΤΟΛΕΙΣ ΤΩΝ ΚΙΝΑΣΩΝ ΣΥΚ Ή JAK

Bauer Shawn M; Jia Zhaozhong J; Song Yonghong; Xu Qing; Mehrotra Mukund; Rose Jack W; Huang Wolin; Venkataramani Chandrasekar; Pandey Anjali

Archive | 2016

2,6-DIAMINO- PYRIMIDIN- 5-YL-CARBOXAMIDES AS SYK OR JAK KINASES INHIBITORS SYK JAK 26---5-YL-

Jia Zhaozhong J; Venkataramani Chandrasekar; Huang Wolin; Mehrotra Mukund; Song Yonghong; Xu Qing; Bauer Shawn M; Pandey Anjali; Kane Brian; Rose Jack W

Archive | 2016

PROTEIN KINASES INHIBITORS

Bauer Shawn M; Jia Zhaozhong J; Song Yonghong; Xu Qing; Mehrotra Mukund; Rose Jack W; Huang Wolin; Venkataramani Chandrasekar; Pandey Anjali

Archive | 2016

1,2,4-TRIAZINE-6-CARBOXAMIDE KINASE INHIBITORS 124--6-

Jia Zhaozhong J; Kane Brian; Rose Jack; Bauer Shawn M; Song Yonghong; Xu Qing; Pandey Anjali

Archive | 2016

2,6-DIAMINOPYRIMIDIN-5-YLCARBOXAMIDER SOM INHIBITORER AF SYK- ELLER JAK-KINASER

Bauer Shawn M; Jia Zhaozhong J; Song Yonghong; Xu Qing; Mehrotra Mukund; Rose Jack W; Huang Wolin; Venkataramani Chandrasekar; Pandey Anjali

Archive | 2015

ΠΑΡΑΓΩΓΑ ΚΙΝΑΖΟΛΙΝΗΣ ΩΣ ΑΝΑΣΤΟΛΕΙΣ ΚΙΝΑΣΗΣ

Pandey Anjali; Scarborough Robert M; Matsuno Kenji; Ichimura Michio; Nomoto Yuji; Ide Shinichi; Tsukuda Eiji; Irie Junko; Oda Shoji

Archive | 2015

FACTOR XA INHIBITORS XA

Song Yonghong; Jia Zhaozhong J; Pandey Anjali; Scarborough Robert M

Archive | 2015

Compuestos derivados de 3-amino-5-[(2-amino-2-oxoetil)amino]pirazina-2-carboxamida, inhibidores de pirazina cinasa; composicion y metodo para tratar una afeccion como enfermedad cardiovascular, trastorno de proliferacion, entre otros

Song Yonghong; Xu Qing; Jia Zhaozhong J; Kane Brian; Bauer Shawn M; Pandey Anjali

Archive | 2014

sais de [4-(6-flúor-7-metil-amino-2-4-dioxo-1,4-dioxo-1,4-diidro-2h-quinazolin-3-il)-fenil]-5-cloro-tiofen-2-il-sulfonilureia, formas e métodos relacionados a eles

Pandey Anjali; Sharp Emma; Wang Juan; Quegan Louisa Jane; Nieder Matthew; Huang Wolin

Explore More

Collaboration

Dive into the Pandey Anjali's collaboration.

Top Co-Authors
Avatar

Scarborough Robert M

Kyowa Hakko Kirin Co.

View shared research outputs
Top Co-Authors
Avatar

Ichimura Michio

Kyowa Hakko Kirin Co.

View shared research outputs
Top Co-Authors
Avatar

Ide Shinichi

Kyowa Hakko Kirin Co.

View shared research outputs
Top Co-Authors
Avatar

Nomoto Yuji

Kyowa Hakko Kirin Co.

View shared research outputs
Top Co-Authors
Avatar

Oda Shoji

Kyowa Hakko Kirin Co.

View shared research outputs
Top Co-Authors
Avatar

Tsukuda Eiji

Kyowa Hakko Kirin Co.

View shared research outputs
Top Co-Authors
Avatar

Matsuno Kenji

Kyowa Hakko Kirin Co.

View shared research outputs
Top Co-Authors
Avatar

Irie Junko

Kyowa Hakko Kirin Co.

View shared research outputs
Top Co-Authors
Avatar

Fujiwara Shigeki

Kyowa Hakko Kirin Co.

View shared research outputs
Top Co-Authors
Avatar

Scarborough Robert

Millennium Pharmaceuticals

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge